BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11744902)

  • 1. Effect of carbon dioxide on human ovarian carcinoma cell growth.
    Smidt VJ; Singh DM; Hurteau JA; Hurd WW
    Am J Obstet Gynecol; 2001 Dec; 185(6):1314-7. PubMed ID: 11744902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proliferation inhibition and apoptosis onset in human ovarian carcinoma cell line SKOV3 induced by Genistein].
    Li Y; Mi C
    Ai Zheng; 2003 Jun; 22(6):586-91. PubMed ID: 12948406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the antiangiogenic effect of Taxol in a human epithelial ovarian carcinoma cell line.
    Hata K; Osaki M; Dhar DK; Nakayama K; Fujiwaki R; Ito H; Nagasue N; Miyazaki K
    Cancer Chemother Pharmacol; 2004 Jan; 53(1):68-74. PubMed ID: 14569416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro exposure to carbon dioxide induces oxidative stress in human peritoneal mesothelial cells.
    Bentes de Souza AM; Wang CC; Chu CY; Briton-Jones CM; Haines CJ; Rogers MS
    Hum Reprod; 2004 Jun; 19(6):1281-6. PubMed ID: 15105394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Establishment and biological characteristics of an immortalized human ovarian sarcomatoid carcinoma cell line BUPH:OVSC-2].
    Feng J; Liu GZ; Fu TY; Ye X; Yao Y
    Ai Zheng; 2002 Jul; 21(7):731-4. PubMed ID: 12479096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CO2 pneumoperitoneum inhibits in vitro proliferation of human carcinoma cells].
    Gutt CN; Bruttel T; Brier C; Paolucci V; Encke A
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):535-40. PubMed ID: 14518312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer.
    Kalli KR; Bradley SV; Fuchshuber S; Conover CA
    Gynecol Oncol; 2004 Sep; 94(3):705-12. PubMed ID: 15350362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP Toxicology and Carcinogenesis Studies of 1,3-Butadiene (CAS No. 106-99-0) in B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 May; 434():1-389. PubMed ID: 12616297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a bioassay for ovarian carcinoma colony-forming cells.
    Hamburger AW; Salmon SE; Alberts DS
    Prog Clin Biol Res; 1980; 48():63-73. PubMed ID: 7208527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of effect of mifepristone on apoptosis of human ovarian cancer cell line 3AO].
    Li Q; Li JJ; Zhao XB; Ji M
    Zhonghua Fu Chan Ke Za Zhi; 2003 Oct; 38(10):625-8. PubMed ID: 14728868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Specific inhibition of HER-2 expression in ovarian carcinoma cells by siRNA targeting HER-2].
    Lu YM; Zhang SL; Meng LR; Zhao YY
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):619-23. PubMed ID: 16681908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
    Pan L; Tong Y; Jin Y; Zhou S; Zhang Y; Yang X; Mao N
    Chin Med J (Engl); 2001 Sep; 114(9):929-32. PubMed ID: 11780384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibitory effect of D-allose on human ovarian carcinoma cells in vitro.
    Sui L; Dong Y; Watanabe Y; Yamaguchi F; Hatano N; Izumori K; Tokuda M
    Anticancer Res; 2005; 25(4):2639-44. PubMed ID: 16080505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of basic fibroblast growth factor in ovarian cancer growth and angiogenesis].
    Lin W; Peng ZL; Zheng A; Bi JH; Huang ZY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):532-5. PubMed ID: 14669225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antitumor effect of endothelial progenitor cells with TRAIL gene transfection on ovarian carcinoma xenografts in nude mice].
    Zhou L; Yan MX; Yao M; Feng YJ
    Ai Zheng; 2005 Nov; 24(11):1312-6. PubMed ID: 16552954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of laparoscopic gases on peritoneal microenvironment and essential parameters of cell function.
    Wildbrett P; Oh A; Naundorf D; Volk T; Jacobi CA
    Surg Endosc; 2003 Jan; 17(1):78-82. PubMed ID: 12360379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors.
    Thaker PH; Yazici S; Nilsson MB; Yokoi K; Tsan RZ; He J; Kim SJ; Fidler IJ; Sood AK
    Clin Cancer Res; 2005 Jul; 11(13):4923-33. PubMed ID: 16000591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of wild-type p53 gene on the chemotherapy sensitivity of ovarian cancer SKOV-3 cells to cisplatin].
    Jin Z; Guan T; Li S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):218-20. PubMed ID: 12048682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancer.
    Popadiuk CM; Xiong J; Wells MG; Andrews PG; Dankwa K; Hirasawa K; Lake BB; Kao KR
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2216-23. PubMed ID: 16609037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.